Syndax: Q4 Earnings Snapshot

By The Associated Press
February 26, 2026 | 5:02 PM

NEW YORK (AP) — NEW YORK (AP) — Syndax Pharmaceuticals Inc. (SNDX) on Thursday reported a loss of $68 million in its fourth quarter.

On a per-share basis, the New York-based company said it had a loss of 78 cents.

The results fell short of Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 64 cents per share.

The biopharmaceutical company posted revenue of $68.7 million in the period, which beat Street forecasts. Four analysts surveyed by Zacks expected $62.4 million.

For the year, the company reported a loss of $285.4 million, or $3.29 per share. Revenue was reported as $172.4 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SNDX at https://www.zacks.com/ap/SNDX

Luigi Mangione in discussions about possible guilty plea, sources say

August 13, 2026 | 2:47 PM

▶ Watch Video: Luigi Mangione due back in federal court Friday Luigi Mangione, accused in the 2024 killing of UnitedHealthcare CEO Brian Thompson, is in discussions about a possible plea deal on federal charges ahead of a court appearance Friday in New York City, sources familiar with the matter told CBS News.Mangione, 28, is set to appear at an 11 a.m. conference in U.S. District Court in Manhattan. That meeting is taking place after prosecutors and the defense team sent a letter to federal court Tuesday requesting Friday's conference.Plea discussions between federal prosecutors and defense attorneys have been ongoing and it's unclear if an agreement has been reached, sources told CBS News.Mangione faces both federal and state charges in connection with Thompson's death. He has pleaded not guilty in both trials."There's speculation they may have a plea deal in the federal case, but we don't know that for sure. It could be a conference about scheduling. It could be a conference about a dispute about discovery. It could be a lot of different things. We're not really gonna know until we see what happens on Friday," legal expert Richard Schoenstein said earlier this week.If a plea deal is reached, it could have an impact on his state trial, which is set to begin next month. That's because of potential double jeopardy concerns."Luigi Mangione's defense team had made that argument in the state case prior, and this could revive it, because if you actually have a conviction on the federal case it's a more robust double jeopardy protection in the New York state case. So we could see a motion there that could kick this state case back," CBS News legal contributor Caroline Polisi said Thursday on "CBS Mornings."The start of his federal trial, if it moves forward, is set for January.This is a developing story. Check back soon for more information.

Related Stories

Democratic senators demand answers about conditions aboard USS Abraham Lincoln

Ataque con bomba en Crimea mata a un excomandante ucraniano que desertó a Rusia

Tropical storm forms near Hawaii, hurricane watch issued for the Big Island

Trump administration's antisemitism lawsuit against Harvard dismissed

This anti-war politician just fled Russia. He believes Putin knows the war is costing him support